
Wockhardt Ltd. share price
NSE: WOCKPHARMA · Healthcare
₹2,004.50 -1.12%
Closing price data, updated 17 Nov 2026. 52-week range: -17.2% from high, +84.5% above low.
Price₹2,004.50
Market cap₹32,572 Cr
P/E79.4
P/B6.31
ROE4.6%
ROCE6.4%
Debt / equity0.45
Dividend yield0.00%
EPS₹25.23
Book value₹317.43
Operating margin12.2%
Dipscan score30 / 100
Share: WhatsAppX / TwitterTelegram
Wockhardt Ltd. shareholding pattern
As of Sep 2026: Promoters 49.32%, FIIs 7.02%, DIIs 9.00%, Government 0.01%, Public 26.90%, Others 7.74%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 49.32% | 49.08% | 49.08% | 49.08% | 49.08% | 49.09% |
| FIIs | 7.02% | 7.22% | 7.09% | 6.99% | 7.10% | 7.29% |
| DIIs | 9.00% | 9.24% | 10.96% | 10.55% | 11.01% | 11.01% |
| Government | 0.01% | 0.02% | 0.04% | 0.02% | 0.02% | 0.02% |
| Public | 26.90% | 27.31% | 25.89% | 26.52% | 26.10% | 26.05% |
| Others | 7.74% | 7.13% | 6.94% | 6.84% | 6.69% | 6.55% |
| No. of Shareholders | 173,116 | 166,518 | 139,016 | 142,274 | 137,946 | 146,918 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| -1.12% | +2.95% | +0.93% | +4.79% | +29.56% | +50.51% |
Growth
| Sales growth, 3 years | +7.8% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | – |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | – |
| Latest quarter profit vs last year | – |
Strengths and weaknesses
Weaknesses
- Stock is trading at 6.31 times its book value
- The company has delivered a poor sales growth of 4.49% over past five years.
- Company has a low return on equity of -1.43% over last 3 years.
- Promoter holding has decreased over last 3 years: -5.81%
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Wockhardt Ltd.?
Wockhardt Ltd. (WOCKPHARMA) last closed at ₹2,004.50 (-1.12% on the day).
What is the market cap of Wockhardt Ltd.?
About ₹32,572 Cr.
What is the P/E ratio of Wockhardt Ltd.?
The price-to-earnings ratio is 79.4, and return on equity is 4.6%.
Figures are calculated from company results and exchange prices and are for information only.